Copyright
©The Author(s) 2020.
World J Crit Care Med. Aug 7, 2020; 9(3): 43-53
Published online Aug 7, 2020. doi: 10.5492/wjccm.v9.i3.43
Published online Aug 7, 2020. doi: 10.5492/wjccm.v9.i3.43
Table 1 Clinical and demographic characteristics of all patients with mechanical ventilation during the study period (n = 263)
| Characteristics, n (%) | Total (n = 263) | VAP (n = 32) | Non-VAP (n = 231) | P value |
| Age (yr)1 | 51.9 ± 17.8 | 49 ± 19.7 | 52.3 ± 17.5 | 0.329 |
| Gender- Masculine | 137 (52.1) | 16 (50) | 110 (47.6) | 0.800 |
| Body mass index1 | 26.2 ± 5.6 | 24.9 ± 4.5 | 26.4 ± 5.7 | 0.188 |
| Solid tumor2 | 188 (68.1) | 25 (67.6) | 163 (68.2) | 0.938 |
| Cervical | 21 (7.6) | 2 (5.4) | 19 (7.9) | 0.749 |
| Head and neck | 21 (7.6) | 3 (8.1) | 18 (7.5) | 1 |
| Colon-rectum | 20 (7.2) | 1 (2.7) | 19 (7.9) | 0.492 |
| Breast | 18 (6.5) | 2 (5.4) | 16 (6.7) | 1 |
| Germinal | 15 (5.4) | 2 (5.4) | 13 (5.4) | 1 |
| Esophagus-stomach | 14 (5.1) | 3 (8.1) | 11 (4.6) | 0.399 |
| Sarcoma | 13 (4.7) | 2 (5.4) | 11 (4.6) | 0.688 |
| Ovarian | 10 (3.6) | 1 (2.7) | 9 (3.8) | 1 |
| Lung | 10 (3.6) | 1 (2.7) | 9 (3.8) | 1 |
| Prostate | 9 (3.3) | 2 (5.4) | 7 (2.9) | 0.348 |
| Liver and bile ducts | 9 (3.3) | 1 (2.7) | 8 (3.3) | 1 |
| Pancreas | 7 (2.5) | 1 (2.7) | 6 (2.5) | 1 |
| Kidney and bladder | 5 (1.8) | 2 (5.4) | 3 (1.3) | 0.136 |
| Other | 16 (5.8) | 2 (5.4) | 14 (5.9) | 1 |
| Hematological malignancies2 | 88 (31.9) | 12 (32.4) | 76 (31.8) | 0.938 |
| Lymphoblastic leukemia | 26 (9.4) | 3 (8.1) | 23 (9.6) | 1 |
| Myeloid leukemia | 12 (4.3) | 3 (8.1) | 9 (3.8) | 0.207 |
| Non-Hodgkin lymphoma | 25 (9.1) | 2 (5.4) | 23 (9.6) | 0.548 |
| Hodgkin lymphoma | 4 (1.5) | 1 (2.7) | 3 (1.2) | 0.439 |
| Multiple myeloma | 14 (5.1) | 2 (5.4) | 12 (5) | 1 |
| Other3 | 7 (2.5) | 1 (2.7) | 6 (2.5) | 1 |
| Cancer stage | ||||
| Recent diagnosis | 117 (44.5) | 11(34.4) | 105 (45.4) | 0.236 |
| Progression | 93 (35.4) | 16 (50) | 78 (33.8) | 0.07 |
| Relapse | 30 (11.4) | 2 (6.2) | 28 (12.1) | 0.551 |
| Partial remission | 21 (8) | 2 (6.2) | 19 (8.2) | 1 |
| Complete remission | 2 (0.7) | 1 (3.1) | 1 (0.4) | 0.228 |
| Chemotherapy within 3 mo | 99 (37.6) | 16 (50) | 83 (35.9) | 0.123 |
| Radiotherapy during the previous 6 mo | 23 (8.7) | 3 (94) | 20 (8.7) | 0.749 |
| Biologic antineoplastic drugs | 22 (8.4) | 6 (18.8) | 16 (6.9) | 0.155 |
| Charlson index | 3 (2, 5) | 3 (2, 5) | 3 (2, 5) | 1 |
| Hospital admission within 3-mo period | 75 (28.5) | 5 (15.6) | 70 (30.3) | 0.09 |
| Days of recent hospitalization4 | 7 (4,12) | 5 (4,9) | 7 (4,12) | 0.544 |
| Recent broad antimicrobials | 36 (13.7) | 1 (3.1) | 35 (15.1) | 0.09 |
- Citation: Cornejo-Juárez P, González-Oros I, Mota-Castañeda P, Vilar-Compte D, Volkow-Fernández P. Ventilator-associated pneumonia in patients with cancer: Impact of multidrug resistant bacteria. World J Crit Care Med 2020; 9(3): 43-53
- URL: https://www.wjgnet.com/2220-3141/full/v9/i3/43.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v9.i3.43